Posted Feb. 27, 2013 at 10:34 a.m.

Premium Lock GSK joint venture strikes patent deal to lower HIV drug costs for children

Published: 2013-02-27 10:34:01
Updated: 2013-02-27 10:34:01

Print this blog post
HIV AIDS research HIV AIDS research

ViiV Healthcare, a joint venture of GlaxoSmithKline and two other drugmakers, plans to license pediatric versions of its HIV drug abacavir to a patent-sharing body backed by the United Nations to improve children's access to treatment and lower costs....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners


Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa